Methimazole-induced insulin autoimmune syndrome.


BACKGROUND Hypoglycemia in a critical care setting is often multifactorial with iatrogenic insulin use, sulfonylurea (SU) use, sepsis, adrenal insufficiency and insulinoma among the common causes. Insulin autoimmune syndrome (IAS) is a rare cause of hypoglycemia characterized by the presence of insulin-binding autoantibodies to the sulfhydryl group… (More)
DOI: 10.1177/2042018816658396


3 Figures and Tables

Cite this paper

@article{Jain2016MethimazoleinducedIA, title={Methimazole-induced insulin autoimmune syndrome.}, author={Nidhi Jain and Malvi Savani and Manyoo Agarwal and Dipen Kadaria}, journal={Therapeutic advances in endocrinology and metabolism}, year={2016}, volume={7 4}, pages={178-81} }